| P2093 | author name string | Young Mee Lee | |
| | Kyunga Kim | |
| | Hyo Jung Park | |
| | So Jin Park | |
| | Yong Won In | |
| | Min-Ji Kim | |
| | Jae Wook Yang | |
| | Na Ri Lim | |
| P2860 | cites work | Vancomycin-associated renal dysfunction: where are we now? | Q38249103 |
| | Vancomycin ototoxicity and nephrotoxicity. A review | Q39542494 |
| | Vancomycin Revisited | Q39736527 |
| | Vancomycin-associated nephrotoxicity in adult medicine patients: incidence, outcomes, and risk factors. | Q42220619 |
| | Increasing vancomycin serum trough concentrations and incidence of nephrotoxicity | Q42772321 |
| | Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections | Q43215440 |
| | High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity | Q45302930 |
| | Elevated vancomycin trough is not associated with nephrotoxicity among inpatient veterans | Q45330387 |
| | Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia | Q46826194 |
| | Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database. | Q53675603 |
| | Acute Renal Failure in Critically Ill Patients A Multinational, Multicenter Study | Q61363260 |
| | A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia | Q80783502 |
| | Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis | Q27021425 |
| | Nephrotoxicity of vancomycin, alone and with an aminoglycoside | Q28335291 |
| | Vancomycin-associated nephrotoxicity: grave concern or death by character assassination? | Q33617737 |
| | Comparative Incidence of Nephrotoxicity by Age Group among Adult Patients Receiving Vancomycin | Q33939091 |
| | Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions | Q34274190 |
| | Vancomycin | Q34420845 |
| | Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists | Q34910366 |
| | Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients | Q34991274 |
| | Effect of vancomycin serum trough levels on outcomes in patients with nosocomial pneumonia due to Staphylococcus aureus: a retrospective, post hoc, subgroup analysis of the Phase 3 ATTAIN studies | Q35141184 |
| | Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial | Q35598479 |
| | The role of vancomycin in the treatment paradigm | Q36328981 |
| | Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity | Q36538707 |
| | Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin | Q36870858 |
| | An overview of drug-induced acute kidney injury | Q37125735 |
| | Pharmacokinetic issues for antibiotics in the critically ill patient | Q37399820 |
| | Vancomycin nephrotoxicity: myths and facts | Q37943110 |
| | Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review | Q37992997 |
| | Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter | Q38061039 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1328-1334 | |
| P577 | publication date | 2018-05-09 | |
| P1433 | published in | International Journal of Clinical Pharmacy | Q15759467 |
| P1476 | title | Evaluation of risk factors for vancomycin-induced nephrotoxicity | |
| P478 | volume | 40 | |